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ABSTRACT
Objective: Pyrazolines are known to exhibit different biological and pharmacological properties such as anticancer, antibacterial, antifungal and 
antitubercular activities. Chalcones with an enone group between two aromatic rings exhibit remarkable pharmacological activities such as anti-
inflammatory, antibacterial, antitumor, antifungal, and antimalarial activity. A series of pyrazolines from chalcones have been synthesized and 
evaluated for antitubercular and cytotoxic activity studies.
Methods: Chalcones [3-substituted phenyl-1-(p-tolyl)prop-2-en-1-one] were synthesized from various substituted aldehydes and 4-methyl 
acetophenone and cyclized into pyrazolines [5-substituted phenyl-3-(p-tolyl)-4,5-dihydro-1H-pyrazole] using hydrazine hydrate. Antitubercular and 
cytotoxic activity studies were carried out.
Results: Antitubercular and cytotoxic activity studies of synthesized pyrazoline revealed that some compounds have showed promising activity.
Conclusion: The observed results proved that pyrazolines are found to be interesting lead molecules for further synthesis as antitubercular and 
cytotoxic agents.
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INTRODUCTION
Nitrogen-containing heterocyclic compounds such as pyrazolines have 
received remarkable attention in the recent years due to their diverse 
pharmacological and biological activities such as antitubercular [1], 
antidepressant [2], anticonvulsant [3], antitumor [4], anti-
inflammatory [5], analgesic [6], antibacterial [7], and anticancer [8]. 
The intermediate used are substituted chalcones derived from 
various substituted aldehydes and ketones which are known for their 
anticancer [9], antioxidant [10], analgesic [11], anti-inflammatory [12], 
and antimalarial [13] activities. Based on the observations, it was 
contemplated to synthesize a novel series pyrazoline derivatives derived 
from substituted chalcones. All the synthesized compounds have been 
screened for their in vitro antitubercular and cytotoxic activity studies.
METHODS
All the chemicals used such as 4-methyl acetophenone, substituted 
benzaldehydes, hydrazine hydrate, sodium hydroxide, ethanol, and 
glacial acetic acid used were of analytical grade. Melting points were 
determined by the capillary method and were uncorrected. The infrared 
(IR) spectra were recorded by using Shimadzu Perkin Ekuner-8201 
Pc IR spectrometer using a thin film on potassium bromide pellets 
techniques, and absorption frequencies are expressed in cm−1. The 
1H Nuclear magnetic resonance (NMR) spectra were recorded on 
Bruker Avance 11400 NMR spectrometer using deuterochloroform 
and DMSO as solvent. Chemical shift values were reported as values in 
ppm relative to tetramethylsilane (δ=0) as an internal standard. Mass 
spectra were recorded on JEOL SX-102/DA-6000 mass spectrometer 
using Argon/Xenon (6 kV, 10 Ma) as the FAB gas. The purity of the 
compounds was checked on silica gel coated plates by using ethyl 
acetate: chloroform (1:9) as a solvent and observed in ultraviolet light.
General procedure
Synthesis of 3-substituted phenyl-1-(p-tolyl)prop-2-en-1-one [14]
A mixture of 4-methyl acetophenone (0.01 mol) and substituted 
benzaldehydes (0.01 mol) in ethanol (20 ml) was stirred for 24 hrs 
in the presence of 20% NaOH (4-5 ml). The mixture was poured into 
crushed ice and acidified with 5% HCl. The product obtained was 
filtered, washed with water, and recrystallized from ethanol.
Synthesis of 5-substituted phenyl-3-(p-tolyl)-4,5-dihydro-1H-
pyrazole [15]
A mixture of substituted chalcones (0.01 mol) in 20 ml of glacial acetic 
acid and hydrazine hydrate (0.01 mol) were added and refluxed for 
16-20 hrs. After the completion of the reaction, the reaction mixture 
was poured into 250 ml of ice cold water. The solid separated was 
filtered, washed with cold water, dried, and recrystallized by using 
ethanol/chloroform. The purity of the compound was checked by using 
ethyl acetate: chloroform (1:9) as a solvent for TLC.
Spectral data
5-(4-chlorophenyl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazole (PZ1)
IR (KBr) cm−1: 1641(C=N str), 2921(C-H aliphatic), 3018(C-H aromatic), 
730(C-Cl str), 1550(C=C str), 1324(C-N str), 3258(N-H str); 1H NMR (δ 
ppm): 2.3 (s, 3H of CH3), 7.2-7.5 (m, 9H, Ar-H), 3.3-3.6 (dd, IH of Ha), 
3.6-3.9 (dd, IH of Hb), 5.3-5.8 (dd, IH of Hc), 7.7 (s, 1H of NH); MS: m/z 
271 (M+1).
3,5-di-p-tolyl-4,5-dihydro-1H-pyrazole (PZ2)
IR (KBr) cm−1: 1639(C=N str), 2918(C-H aliphatic), 3015(C-H aromatic), 
1545 (C=C str), 1318(C-N str); 1H NMR (δ ppm): 2.2 (s, 3H of CH3), 7.1-
7.5 (m, 9H, Ar-H), 3.4-3.7(dd, IH of Ha), 3.7-4.0 (dd, IH of Hb), 5.4-5.8 (dd, 
IH of Hc), 7.6 (s, 1H of NH); MS: m/z 250 (M+).
5-(4-nitrophenyl)- 3-(p-tolyl)- 4,5-dihydro-1H-pyrazole (PZ3)
IR (KBr) cm−1: 1648(C=N str), 2914(C-H aliphatic), 3024(C-H 
aromatic str), 1540(C=C str), 1314(C-N str), 1428(Ar-NO2 str); 1H NMR 
(δ ppm): 2.1 (s, 3H of CH3), 7.2-7.6 (m, 9H, Ar-H), 3.5-3.7 (dd, IH of Ha), 
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3.8-4.1 (dd, IH of Hb), 5.4-5.9 (dd, IH of Hc), 7.8 (s, 1H of NH); MS: m/z 
281 (M+).
Antitubercular activity using microplate alamar blue assay 
(MABA) [16]
The antimycobacterial activity of synthesized compounds was 
assessed against Mycobacterium tuberculosis using MABA. The 96 
well plate received 10 µl of the Middlebrook 7H9 broth and serial 
dilution of compounds were made directly on the plate. The final 
drug concentrations of the tested compounds were 0.2-100 µl/ml and 
standards used are INH. Plates were covered and sealed with parafilm 
and incubated at 37°C for 7 days. After this, 25 µl of freshly prepared 
1:1 mixture of Alamar blue reagent and 10% tween 80 was added to the 
plate and incubated for 24 hrs. The presence of blue color in the well 
indicated no bacterial growth and appearance of pink color indicated 
the growth. The minimum inhibitory concentration (MIC) was defined 
as lowest drug concentration which prevented the color change from 
blue to pink. The MIC data are given in Table 2. Compounds PZ1, PZ3, 
PZ4, PZ5, and PZ6 have shown significant antitubercular activity with 
MIC ranging from 7.5 to 18 µg/ml.
Cytotoxic activity
All the test compounds were screened for cytotoxic activity against 
Ehrlich Ascites Carcinoma (EAC) cells. The tumor cells aspirated from 
the peritoneal cavity of tumor-bearing mice was washed thrice with 
normal saline and checked for viability using Trypan blue exclusion 
method [17]. The cell suspension (1 million cells in 0.1 ml) was added 
to tubes containing various concentrations of the test compounds and 
volume was made up to 1 ml using phosphate buffered saline. Control 
tubes contained only cell suspension. The assay mixtures were incubated 
for 3 hrs, at 37°C, and then, percent of dead cells were evaluated by 
trypan blue exclusion method. Compounds PZ1, PZ3, and PZ5 induced 
Compound code R Molecule weight M.P°C Physical state % yield
PZ1 4-Cl 270 136-138 White crystals 72
PZ2 4-CH3 250 92-94 White crystals 71
PZ3 4-NO2 281 168-170 Yellow crystals 69
PZ4 4-OH 252 116-118 Brown crystals 65
PZ5 4-Br 301 176-178 Orange crystals 74
PZ6 4-F 254 152-154 White crystals 73
Fig. 1: Scheme for pyrazoline derivatives
Table 1: Physical data of the synthesized compounds
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the greatest effect on EAC cells with an activity more than 60% at a 
concentration of 200 µg/ml. The results are summarized in Table 3.
RESULTS AND DISCUSSION
Antitubercular activity
The test compounds were evaluated for their antitubercular activity 
against M. tuberculosis using MABA. A blue color in the well was 
interpreted as no bacterial growth, and pink color was scored as growth. 
This indicates that the test compound has potent antitubercular activity 
under in vitro condition. Compounds PZ1, PZ3, PZ4, PZ5, and PZ6 have 
shown significant antitubercular activity with MIC ranging from 7.5 to 
18 µg/ml compared to the standard drug isoniazid. The presence of 
pyrazoline moiety with substitution and groups such as chloro, nitro, 
hydroxy, bromo, and fluoro resulted in significant antitubercular activity.
Cytotoxic activity
The test compounds were screened for their cytotoxic activity against 
EAC cells using trypan blue exclusion method. Compounds PZ1, PZ3, 
and PZ5 induced significant effect on EAC cells with an activity more 
than 60% at a concentration of 200 µg/ml. The presence of pyrazoline 
moiety with electron withdrawing groups such as chloro, nitro, and 
bromo has accounted for their remarkable cytotoxic activity.
CONCLUSION
The study reports the successful synthesis of pyrazoline derivatives 
with moderate yields, and most of the synthesized compounds showed 
potent antitubercular and cytotoxic activities.
Table 2: Antitubercular activity of compounds (PZ1‑PZ6) by 
microplate alamar blue assay








MIC: Minimum inhibitory concentration
Table 3: Cytotoxic activity of compounds (PZ1‑PZ6) by Trypan 
blue exclusion method 
Compounds Number of dead cells (%) at different 
concentrations (µg/ml)
10 20 50 100 200
Control - - - - -
PZ1 11 21 36 53 65
PZ2 07 16 20 35 35
PZ3 10 23 37 54 70
PZ4 05 19 29 37 42
PZ5 05 20 30 31 50
PZ6 12 32 46 56 75
5-fluorouracil 20 35 50 85 95
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